Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)

Dr. Amit Agarwal

Internal Medicine
HackenSack Meridian health
Das Medical Associates
1 Sears Drive, Suite 402, 
Paramus, NJ 
Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)
HackenSack Meridian health
Das Medical Associates
1 Sears Drive, Suite 402, 
Paramus, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amit Agarwal is a primary care provider, practicing in Internal Medicine in Paramus, New Jersey. Dr. Agarwal is rated as an Experienced provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). His top areas of expertise are Tracheobronchomalacia, Acute Kidney Failure, Lung Cancer, Parathyroidectomy, and Thyroidectomy.

His clinical research consists of co-authoring 699 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Multisystem Inflammatory Syndrome in Children (MIS-C).

Graduate Institution
Ross University School Of Medicine-Dominica
Residency
Trinitas Regional Medical Center
Specialties
Internal Medicine
Licenses
Internal Medicine in MN
Board Certifications
American Board Of Internal Medicine
Hospital Affiliations
Hackensack University Medical Center
Valley Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Das Medical Associates
1 Sears Drive, Suite 402, Paramus, NJ 7652.
Call: 201-483-9188

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Procedure
Study Drugs: Lenalidomide, Bortezomib, Dexamethasone
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drugs: ACY-241, Pomalidomide, Dexamethasone
Study Phase: Phase 1
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.
Journal: Blood
Published: June 06, 2017
View All 3 Publications
Similar Doctors
Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Arun Sehgal
Internal Medicine | General Practice
Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Arun Sehgal
Internal Medicine | General Practice

Preventive And Diagonostic Medical Center P.A.

27 S Franklin Tpke, Suite 201, 
Ramsey, NJ 
 (7.8 miles away)
201-818-6800
Languages Spoken:
English, Punjabi
See accepted insurances
Accepting New Patients

Arun Sehgal is a primary care provider, practicing in Internal Medicine and General Practice in Ramsey, New Jersey. Dr. Sehgal is rated as a Distinguished provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). His top areas of expertise are Dementia, Hypertension, Glucocorticoid-Remediable Aldosteronism, Hip Replacement, and Gastrostomy. Dr. Sehgal is currently accepting new patients.

Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Raymond S. Basri
Internal Medicine
Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Raymond S. Basri
Internal Medicine
236 Crystal Run Rd, Suite 2, 
Middletown, NY 
 (37.4 miles away)
845-692-3100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Raymond Basri is a primary care provider, practicing in Internal Medicine in Middletown, New York. Dr. Basri is rated as a Distinguished provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Glossitis, and Pernicious Anemia.

Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Eli S. Djebiyan
Internal Medicine
Distinguished in Multisystem Inflammatory Syndrome in Children (MIS-C)
Dr. Eli S. Djebiyan
Internal Medicine

Excelcare Medical Associates PA

140 Grand Ave, Suite 3, 
Englewood, NJ 
 (6.7 miles away)
201-569-9010
Languages Spoken:
English, Armenian, Bulgarian, German, Polish, Russian, Spanish, Turkish
See accepted insurances
Accepting New Patients

Eli Djebiyan is a primary care provider, practicing in Internal Medicine in Englewood, New Jersey. Dr. Djebiyan is rated as a Distinguished provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). Her top areas of expertise are Sepsis, Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Gastrostomy, and Endoscopy. Dr. Djebiyan is currently accepting new patients.

VIEW MORE MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Agarwal's expertise for a condition
ConditionClose
    • Distinguished
    • Tracheobronchomalacia
      Dr. Agarwal is
      Distinguished
      . Learn about Tracheobronchomalacia.
      See more Tracheobronchomalacia experts
    • Advanced
    • Acute Kidney Failure
      Dr. Agarwal is
      Advanced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Adrenal Cancer
      Dr. Agarwal is
      Advanced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Bone Graft
      Dr. Agarwal is
      Advanced
      . Learn about Bone Graft.
      See more Bone Graft experts
    • Bowlegs
      Dr. Agarwal is
      Advanced
      . Learn about Bowlegs.
      See more Bowlegs experts
    • COVID-19
      Dr. Agarwal is
      Advanced
      . Learn about COVID-19.
      See more COVID-19 experts
    • Endoscopy
      Dr. Agarwal is
      Advanced
      . Learn about Endoscopy.
      See more Endoscopy experts
    View All 25 Advanced Conditions
    • Experienced
    • Absence Seizure
      Dr. Agarwal is
      Experienced
      . Learn about Absence Seizure.
      See more Absence Seizure experts
    • Acute Interstitial Pneumonia
      Dr. Agarwal is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Acute Pain
      Dr. Agarwal is
      Experienced
      . Learn about Acute Pain.
      See more Acute Pain experts
    • Acute Pancreatitis
      Dr. Agarwal is
      Experienced
      . Learn about Acute Pancreatitis.
      See more Acute Pancreatitis experts
    • Adrenocortical Carcinoma
      Dr. Agarwal is
      Experienced
      . Learn about Adrenocortical Carcinoma.
      See more Adrenocortical Carcinoma experts
    • Allergic Conjunctivitis
      Dr. Agarwal is
      Experienced
      . Learn about Allergic Conjunctivitis.
      See more Allergic Conjunctivitis experts
    View All 238 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.